BioPharma
Biopharma Enhancing Visibility in Connected Supply Chain
The biopharmaceutical industry, with a market value exceeding $350 billion, stands as a cornerstone of global health innovation. The emergence of the Covid-19 pandemic underscored...
BioPharma
Cell And Gene Therapy Market Soars, Forecasted At $82.24B
The global cell and gene therapy market has witnessed remarkable growth, with a market size of USD 15.46 billion in 2022. Projections indicate that by...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant challenges....
BioPharma
Key Steps For Biopharma Startups Getting Ready For EU HTA
What is the Joint European HTA?
Navigating pricing and reimbursement in the European Union (EU) can be a complex task for emerging biopharmaceutical companies (EBPs), defined...
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal to a successful pharmaceutical development journey. This decision hinges on...
BioPharma
Overcoming Challenges In Biopharma Novel Drug Manufacturing
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized therapies,...
BioPharma
Enhanced Biopharmaceutical Release: Autonomous PAT Power
Speeding up biomanufacturing using automated Process Analytical Technology (PAT) systems
A2P2 and Micro Sequential Injection (SI), two cutting-edge process analysers, have been cited as autonomous PAT...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.